Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial
Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial
Alejandro Torres, Sammy Elmariah, Jamil Aboulhosn, Shabana Shahanavaz et al.
Journal
Circulation Cardiovascular Interventions
Topics
Cardiac Valve Diseases and Treatments
article
Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial
Alejandro Torres, Sammy Elmariah, Jamil Aboulhosn, Shabana Shahanavaz, Matthew J. Gillespie, Thomas K. Jones, Richard A. Krasuski, Michael Hainstock, Alan Zajarías, Zachary L. Steinberg, Vaikom S. Mahadevan, Andrew Leventhal, Kun Li, Dennis Kim, Phillip Moore, Gregory Fleming, Vasilis Babaliaros, Girish Shirali, Daniel Levi, Dean Kereiakes, Robert Sommer, Wilson Szeto, D. Scott Lim, Robert Gray
article en
Abstract
No abstract available for this paper.
Publication Tag
Circulation Cardiovascular Interventions
Institutions
Cincinnati Children's Hospital Medical Center (US), Barnes-Jewish Hospital (US), Primary Children's Hospital (US), Children's Mercy Hospital (US), Vancouver Coastal Health (CA), University of Kentucky (US), Emory University (US), University of California, Los Angeles (US), Duke University (US), University of California, San Francisco (US), American Jewish University (US), Columbia University Irving Medical Center (US), University of Washington Medical Center (US), Memorial Medical Center (US), Jewish Hospital (US), Seattle Children's Hospital (US), Mercy Hospital (US), Duke Medical Center (US), Christ Hospital (US), Edwards Lifesciences (United States) (US), Christ Hospital (US), University of Virginia (US), University of Pennsylvania (US)